ProPhase Labs, Inc. (PRPH) NASDAQ
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In USD
Address
711 Stewart Avenue
Garden City, NY 11530
United States of America (the)
Phone
215 345 0919
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
96
First IPO Date
April 04, 1994
| Name | Title | Pay | Year Born |
| Ted William Karkus | Chairman & Chief Executive Officer | 903,200 | 1959 |
| Kevin Quinn | Chief Product Officer of Nebula Genomics | 0 | N/A |
| Jason Karkus | President of Nebula Genomics | 0 | N/A |
ProPhase Labs, Inc., founded in 1989 in Garden City, New York (and previously known as The Quigley Corporation), operates as a diversified company with two main areas of focus: Consumer Products and Diagnostic Services. Through its Consumer Products division, ProPhase Labs is actively involved in the entire process—from researching and developing to manufacturing, distributing, marketing, and selling—a range of over-the-counter (OTC) healthcare items and nutritional supplements within the United States. Notable offerings include dietary supplements like Legendz XL, which supports male sexual health, and Triple Edge XL, formulated to enhance energy and stamina. The Diagnostic Services segment provides crucial testing solutions, including PCR tests for SARS-CoV-2 (COVID-19) and its variant mutations, using both saliva and nasal swab collection methods. This segment also offers molecular testing for other respiratory pathogens and supplies personal genomics products and services. Additionally, ProPhase Labs extends its capabilities by providing comprehensive contract manufacturing services, covering product development, pre-commercialization activities, production, warehousing, and distribution. The company's diverse products and services reach consumers through a broad network of national chain drug stores, various regional retailers, and online platforms.